MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway

References

• Luetke A, Meyers PA, Lewis I, et al. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev. 2014;40(4):523–532.
   PubMed Web of Science ®Google Scholar
• Arndt CA, Rose PS, Folpe AL, et al. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012;87(5):475–487.
   PubMed Web of Science ®Google Scholar
• Kager L, Tamamyan G, Bielack S. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol. 2017;13(4):357–368.
   PubMed Web of Science ®Google Scholar
• Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):vii320–5.
   PubMed Web of Science ®Google Scholar
• Wedekind MF, Wagner LM, Cripe TP. Immunotherapy for osteosarcoma: where do we go from here? Pediatr Blood Cancer. 2018;65(9):e27227.
   PubMed Web of Science ®Google Scholar
• Feng H, Gu ZY, Li Q, et al. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis. J Ovarian Res. 2019;12(1):35.
   PubMedGoogle Scholar
• Dai GP, Wang LP, Wen YQ, et al. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis. Oncol Lett. 2020;19(1):388–398.
   PubMed Web of Science ®Google Scholar
• Diao C, Xi Y, Xiao T. Identification and analysis of key genes in osteosarcoma using bioinformatics. Oncol Lett. 2018;15(3):2789–2794.
   PubMed Web of Science ®Google Scholar
• Xie B, Li Y, Zhao R, et al. Identification of key genes and miRNAs in osteosarcoma patients with chemoresistance by bioinformatics analysis. Biomed Res Int. 2018;2018:4761064.
   PubMed Web of Science ®Google Scholar
• Feng H, Jia XM, Gao NN, et al. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-beta signaling pathway. Cell Cycle. 2019;18(21):2860–2875.
   PubMed Web of Science ®Google Scholar
• Qu LS, Jin F, Guo YM, et al. Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study. Oncol Lett. 2016;11(1):624–632.
   PubMed Web of Science ®Google Scholar
• Kollara A, Shathasivam P, Park S, et al. Increased androgen receptor levels and signaling in ovarian cancer cells by VEPH1 associated with suppression of SMAD3 and AKT activation. J Steroid Biochem Mol Biol. 2020;196:105498.
   PubMed Web of Science ®Google Scholar
• Shathasivam P, Kollara A, Spybey T, et al. VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation. Br J Cancer. 2017;116(8):1065–1076.
   PubMed Web of Science ®Google Scholar
• Tenbaum SP, Ordonez-Moran P, Puig I, et al. beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med. 2012;18(6):892–901.
   PubMed Web of Science ®Google Scholar
• Lin J, Marquardt G, Mullapudi N, et al. Lung cancer transcriptomes refined with laser capture microdissection. Am J Pathol. 2014;184(11):2868–2884.
   PubMed Web of Science ®Google Scholar
• Ready D, Yagiz K, Amin P, et al. Mapping the STK4/Hippo signaling network in prostate cancer cell. PLoS One. 2017;12(9):e0184590.
   PubMed Web of Science ®Google Scholar
• Brown TJ, Kollara A, Shathasivam P, et al. Ventricular Zone Expressed PH Domain Containing 1 (VEPH1): an adaptor protein capable of modulating multiple signaling transduction pathways during normal and pathological development. Cell Commun Signal. 2019;17(1):116.
   PubMed Web of Science ®Google Scholar
• Liu B, Li J, Cairns MJ. Identifying miRNAs, targets and functions. Brief Bioinform. 2014;15(1):1–19.
   PubMed Web of Science ®Google Scholar
• Ling H, Fabbri M, Ga C. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12(11):847–865.
   PubMed Web of Science ®Google Scholar
• Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5ʹ UTR as in the 3ʹ UTR. Proc Natl Acad Sci U S A. 2007;104(23):9667–9672.
   PubMed Web of Science ®Google Scholar
• Kanellopoulou C, Monticelli S. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer. Semin Cancer Biol. 2008;18(2):79–88.
   PubMed Web of Science ®Google Scholar
• Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis. 2012;33(6):1126–1133.
   PubMed Web of Science ®Google Scholar
• Qadir MI, Faheem A. miRNA: a diagnostic and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene Expr. 2017;27(3):197–204.
   PubMed Web of Science ®Google Scholar
• Sun Z, Gao S, Xuan L, et al. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis. J Cell Mol Med. 2020;24(7):4275–4285.
   PubMed Web of Science ®Google Scholar
• Xian X, Tang L, Wu C, et al. miR-23b-3p and miR-130a-5p affect cell growth, migration and invasion by targeting CB1R via the Wnt/beta-catenin signaling pathway in gastric carcinoma. Onco Targets Ther. 2018;11:7503–7512.
   PubMed Web of Science ®Google Scholar
• He RQ, Wu PR, Xiang XL, et al. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: a study based on public data and RT-qPCR verification. Int J Mol Med. 2018;41(5):2813–2831.
   PubMed Web of Science ®Google Scholar
• Zaman MS, Thamminana S, Shahryari V, et al. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One. 2012;7(11):e50203.
   PubMed Web of Science ®Google Scholar
• Zhu R, Li X, Ma Y. miR-23b-3p suppressing PGC1alpha promotes proliferation through reprogramming metabolism in osteosarcoma. Cell Death Dis. 2019;10(6):381.
   PubMedGoogle Scholar
• Yang Q, Jiang W, Hou P. Emerging role of PI3K/AKT in tumor-related epigenetic regulation. Semin Cancer Biol. 2019;59:112–124.
   PubMed Web of Science ®Google Scholar
• Aoki M, Fujishita T. Oncogenic roles of the PI3K/AKT/mTOR axis. Curr Top Microbiol Immunol. 2017;407:153–189.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu XH, Yan YG, et al. PI3K/Akt signaling in osteosarcoma. Clin Chim Acta. 2015;444:182–192.
   PubMed Web of Science ®Google Scholar
• Wu L, Liu C, Zhang Z. Knockdown of lncRNA MIAT inhibits proliferation and cisplatin resistance in non-small cell lung cancer cells by increasing miR-184 expression. Oncol Lett. 2020;19(1):533–541.
   PubMed Web of Science ®Google Scholar
• Doyle LA. Sarcoma classification: an update based on the 2013 World Health Organization classification of tumors of soft tissue and bone. Cancer. 2014;120(12):1763–1774.
   PubMed Web of Science ®Google Scholar
• Zhang H, Jiang H, Zhang H, et al. Anti-tumor efficacy of phellamurin in osteosarcoma cells: involvement of the PI3K/AKT/mTOR pathway. Eur J Pharmacol. 2019;858:172477.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Lu J, Lin J, Zhou Y, et al. MiR-328-3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1. Biochem Biophys Res Commun. 2021;550:99–106.
   PubMed Web of Science ®Google Scholar
• Zhuang Z, Xiao Q, Hu H, et al. Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway. Mol Vis. 2015;21:1173–1184.
   PubMed Web of Science ®Google Scholar
• Guo L, Fu J, Sun S, et al. MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer Sci. 2019;110(2):805–816.
   PubMed Web of Science ®Google Scholar
• Song AF, Kang L, Wang YF, et al. MiR-34a-5p inhibits fibroblast–like synoviocytes proliferation via XBP1. Eur Rev Med Pharmacol Sci. 2020;24(22):11675–11682.
   PubMed Web of Science ®Google Scholar
• Song W, Zhang T, Yang N, et al. Inhibition of micro RNA miR-122-5p prevents lipopolysaccharide-induced myocardial injury by inhibiting oxidative stress, inflammation and apoptosis via targeting GIT1. Bioengineered. 2021;12(1):1902–1915.
   PubMed Web of Science ®Google Scholar
• Wang G, Li B, Fu Y, et al. miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1. Tumour Biol. 2015;36(6):4715–4721.
   PubMedGoogle Scholar
• Xu CH, Xiao LM, Liu Y, et al. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2. Eur Rev Med Pharmacol Sci. 2019;23(1):241–252.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Y, Wang L, et al. miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP. Biomed Pharmacother. 2018;107:424–432.
   PubMed Web of Science ®Google Scholar
• Lu M, Ding N, Zhuang S, et al. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells. Mol Cell Biochem. 2020;469:9–19 .
   PubMed Web of Science ®Google Scholar
• Taran SJ, Taran R, Malipatil NB. Pediatric Osteosarcoma: an Updated Review. Indian J Med Paediatr Oncol. 2017;38(1):33–43.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Calin GA, Lopez-Berestein G, et al. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016;6(3):235–246.
   PubMed Web of Science ®Google Scholar
• Yang F, Ning Z, Ma L, et al. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts. Mol Cancer. 2017;16(1):148.
   PubMed Web of Science ®Google Scholar
• Sasaki R, Osaki M, Okada F. MicroRNA-based diagnosis and treatment of metastatic human osteosarcoma. Cancers (Basel). 2019;11(4):553.
   PubMed Web of Science ®Google Scholar
• Cao Q, Wang Z, Wang Y, et al. TBL1XR1 promotes migration and invasion in osteosarcoma cells and is negatively regulated by miR-186-5p. Am J Cancer Res. 2018;8(12):2481–2493.
   PubMed Web of Science ®Google Scholar
• Ji Q, Xu X, Song Q, et al. miR-223-3p inhibits human osteosarcoma metastasis and progression by directly targeting CDH6. Mol Ther. 2018;26(5):1299–1312.
   PubMed Web of Science ®Google Scholar
• Wu B, Xing C, Tao J. Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells. J Orthop Surg Res. 2019;14(1):398.
   PubMed Web of Science ®Google Scholar
• Liu H, Wei W, Wang X, et al. miR23b3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1. Mol Med Rep. 2018;18(6):5683–5692.
   PubMed Web of Science ®Google Scholar
• Shathasivam P, Kollara A, Ringuette MJ, et al. Human ortholog of Drosophila melted impedes SMAD2 release from TGF-beta receptor I to inhibit TGF-beta signaling. Proc Natl Acad Sci U S A. 2015;112(23):E3000–9.
   PubMed Web of Science ®Google Scholar
• Han JA, Kim JY, Kim JI. Analysis of gene expression in cyclooxygenase-2-overexpressed human osteosarcoma cell lines. Genomics Inform. 2014;12(4):247–253.
   PubMedGoogle Scholar
• Li Y, Song X, Liu Z, et al. Upregulation of miR-214 induced radioresistance of osteosarcoma by targeting PHLDA2 via PI3K/Akt signaling. Front Oncol. 2019;9:298.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen D, Zhang G, et al. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways. Oncol Lett. 2020;20(5):160.
   PubMed Web of Science ®Google Scholar